We are live on
!
Find out more
CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
12 hedge funds and large institutions have $769K invested in Cyclo Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
3% less capital invested
Capital invested by funds: $795K → $769K (-$26K)
8% less funds holding
Funds holding: 13 → 12 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
12
Holders Change
-1
Holders Change %
-7.69%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
LPL Financial
San Diego,
California
|
+$21.1K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.84K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.26K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$32.5K |
| 2 |
Citigroup
New York
|
-$2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2K |